PATENT CLAIM ANALYSIS

Application Number: 16003232
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-09
Patent Classification: ["548", "301100"]

Abstract:
The present invention encompasses compounds of formula (I) wherein the groups R 1  to R 4 , R 7 , A, D, E, F, V, W, X, Y, n, r and q are defined in claim  1,  their use as inhibitors of MDM2-p53 interaction, pharmaceutical compositions which contain compounds of this kind, their use as medicaments, especially as agents for treatment and/or prevention of oncological diseases, and synthetic intermediates.

Claim (Index 21):
A pharmaceutical composition comprising at least one compound according  claim 1  or a pharmaceutically acceptable salt thereof\u2014and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 94.0
- Lexical Diversity: 1.45763
- Patent Class: 548.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15503754', '15287958', '14790032', '14683173', '13746411']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7753166908059922
- 35 USC 102 Novelty (BERT): 0.5635447687255547
- Combined Prediction Score: 0.7541394985979485
- Mean Citation Score: 386.50986600000016
- Max Citation Score: 452.09863
- Similarity Product: 402.33783591764745

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test